Predictive Factors for Lateral Lymph Node Metastasis and Skip Metastasis in Papillary Thyroid Carcinoma
In papillary thyroid cancer (PTC) patients, cervical lymph node metastases are common, which disseminate sequentially from the central neck to the lateral neck. However, there is also a chaotic pattern of lymph node metastasis occasionally. In this study, we summarized 653 PTC patients who underwent...
Gespeichert in:
Veröffentlicht in: | Endocrine pathology 2020-03, Vol.31 (1), p.67-76 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 76 |
---|---|
container_issue | 1 |
container_start_page | 67 |
container_title | Endocrine pathology |
container_volume | 31 |
creator | Feng, Jia-Wei Qin, An-Cheng Ye, Jing Pan, Hua Jiang, Yong Qu, Zhen |
description | In papillary thyroid cancer (PTC) patients, cervical lymph node metastases are common, which disseminate sequentially from the central neck to the lateral neck. However, there is also a chaotic pattern of lymph node metastasis occasionally. In this study, we summarized 653 PTC patients who underwent thyroidectomy and central lymph node dissection with or without lateral lymph node dissection from two hospitals to investigate the pattern and risk factors of lateral lymph node metastasis (LLNM) and skip metastasis. LLNM was significantly associated tumor size > 1 cm, presence of extrathyroidal extension, tumors in the upper-lateral pole, and the number of metastatic lymph nodes in the central compartment. The frequency of skip metastasis was 22.5% (20 of 89 patients). Multivariate analyses showed tumor size ≤ 1 cm, and tumors in the upper-lateral pole were separately and independently associated with the risk of skip metastasis. Presence of LLNM affected the recurrence-free survival (RFS). RFS did not show the significantly difference between patients with LLNM and skip metastasis. Despite the low incidence of skip metastasis, attention should be paid to the possibility of LLNM even in the absence of central lymph node metastases. Besides, for patients with risk factors of LLNM or skip metastasis, detailed preoperative examination for the lateral compartment, especially the level III, is essential. |
doi_str_mv | 10.1007/s12022-019-09599-w |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2325298579</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2362191956</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-b715dbd6e78b02a3998702baa6112dc9e0120f7e9ab4de2d5b2cfa5be81268d03</originalsourceid><addsrcrecordid>eNqNkVFrFTEQhYMotlb_gA8S8EWQrZOk2WweZbEq3GrB-rxkk9k29W6yJrte7r9vdGsrPogQSCZ8Z5gzh5DnDI4ZgHqTGQfOK2C6Ai21rnYPyCGTspSg1cPyhpO6ElrVB-RJztcATADwx-RAsIY3shGH5PI8ofN29j-Qnho7x5TpEBPdmBmT2dLNfpyu6KfokJ7hbHI5PlMTHP3yzU9__vlAz83kt1uT9vTiap-id7Q1yfoQR_OUPBrMNuOz2_uIfD19d9F-qDaf339s324qK5Scq14x6XpXo2p64EZo3SjgvTE1Y9xZjVA8Dwq16U8ccid7bgcje2wYrxsH4oi8WvtOKX5fMM_d6LPFMlXAuOSOCy65bqTSBX35F3odlxTKdIWqOdNMy7pQfKVsijknHLop-bF47Bh0P2Po1hi6EkP3K4ZuV0Qvblsv_YjuTvJ77wVoVmCHfRyy9Rgs3mEAIJkuCylxAYPWz2b2MbRxCXORvv5_aaHFSudChEtM9yb_Mf8NliK0YQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2362191956</pqid></control><display><type>article</type><title>Predictive Factors for Lateral Lymph Node Metastasis and Skip Metastasis in Papillary Thyroid Carcinoma</title><source>SpringerLink Journals - AutoHoldings</source><creator>Feng, Jia-Wei ; Qin, An-Cheng ; Ye, Jing ; Pan, Hua ; Jiang, Yong ; Qu, Zhen</creator><creatorcontrib>Feng, Jia-Wei ; Qin, An-Cheng ; Ye, Jing ; Pan, Hua ; Jiang, Yong ; Qu, Zhen</creatorcontrib><description>In papillary thyroid cancer (PTC) patients, cervical lymph node metastases are common, which disseminate sequentially from the central neck to the lateral neck. However, there is also a chaotic pattern of lymph node metastasis occasionally. In this study, we summarized 653 PTC patients who underwent thyroidectomy and central lymph node dissection with or without lateral lymph node dissection from two hospitals to investigate the pattern and risk factors of lateral lymph node metastasis (LLNM) and skip metastasis. LLNM was significantly associated tumor size > 1 cm, presence of extrathyroidal extension, tumors in the upper-lateral pole, and the number of metastatic lymph nodes in the central compartment. The frequency of skip metastasis was 22.5% (20 of 89 patients). Multivariate analyses showed tumor size ≤ 1 cm, and tumors in the upper-lateral pole were separately and independently associated with the risk of skip metastasis. Presence of LLNM affected the recurrence-free survival (RFS). RFS did not show the significantly difference between patients with LLNM and skip metastasis. Despite the low incidence of skip metastasis, attention should be paid to the possibility of LLNM even in the absence of central lymph node metastases. Besides, for patients with risk factors of LLNM or skip metastasis, detailed preoperative examination for the lateral compartment, especially the level III, is essential.</description><identifier>ISSN: 1046-3976</identifier><identifier>EISSN: 1559-0097</identifier><identifier>DOI: 10.1007/s12022-019-09599-w</identifier><identifier>PMID: 31828583</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Biopsy ; Endocrinology ; Endocrinology & Metabolism ; Life Sciences & Biomedicine ; Lymph nodes ; Lymphatic system ; Medicine ; Medicine & Public Health ; Metastases ; Metastasis ; Oncology ; Papillary thyroid cancer ; Papillary thyroid carcinoma ; Pathology ; Risk factors ; Science & Technology ; Thyroid cancer ; Thyroidectomy ; Tumors</subject><ispartof>Endocrine pathology, 2020-03, Vol.31 (1), p.67-76</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2019</rights><rights>Endocrine Pathology is a copyright of Springer, (2019). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>46</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000519375300010</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c375t-b715dbd6e78b02a3998702baa6112dc9e0120f7e9ab4de2d5b2cfa5be81268d03</citedby><cites>FETCH-LOGICAL-c375t-b715dbd6e78b02a3998702baa6112dc9e0120f7e9ab4de2d5b2cfa5be81268d03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12022-019-09599-w$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12022-019-09599-w$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31828583$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Feng, Jia-Wei</creatorcontrib><creatorcontrib>Qin, An-Cheng</creatorcontrib><creatorcontrib>Ye, Jing</creatorcontrib><creatorcontrib>Pan, Hua</creatorcontrib><creatorcontrib>Jiang, Yong</creatorcontrib><creatorcontrib>Qu, Zhen</creatorcontrib><title>Predictive Factors for Lateral Lymph Node Metastasis and Skip Metastasis in Papillary Thyroid Carcinoma</title><title>Endocrine pathology</title><addtitle>Endocr Pathol</addtitle><addtitle>ENDOCR PATHOL</addtitle><addtitle>Endocr Pathol</addtitle><description>In papillary thyroid cancer (PTC) patients, cervical lymph node metastases are common, which disseminate sequentially from the central neck to the lateral neck. However, there is also a chaotic pattern of lymph node metastasis occasionally. In this study, we summarized 653 PTC patients who underwent thyroidectomy and central lymph node dissection with or without lateral lymph node dissection from two hospitals to investigate the pattern and risk factors of lateral lymph node metastasis (LLNM) and skip metastasis. LLNM was significantly associated tumor size > 1 cm, presence of extrathyroidal extension, tumors in the upper-lateral pole, and the number of metastatic lymph nodes in the central compartment. The frequency of skip metastasis was 22.5% (20 of 89 patients). Multivariate analyses showed tumor size ≤ 1 cm, and tumors in the upper-lateral pole were separately and independently associated with the risk of skip metastasis. Presence of LLNM affected the recurrence-free survival (RFS). RFS did not show the significantly difference between patients with LLNM and skip metastasis. Despite the low incidence of skip metastasis, attention should be paid to the possibility of LLNM even in the absence of central lymph node metastases. Besides, for patients with risk factors of LLNM or skip metastasis, detailed preoperative examination for the lateral compartment, especially the level III, is essential.</description><subject>Biopsy</subject><subject>Endocrinology</subject><subject>Endocrinology & Metabolism</subject><subject>Life Sciences & Biomedicine</subject><subject>Lymph nodes</subject><subject>Lymphatic system</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Oncology</subject><subject>Papillary thyroid cancer</subject><subject>Papillary thyroid carcinoma</subject><subject>Pathology</subject><subject>Risk factors</subject><subject>Science & Technology</subject><subject>Thyroid cancer</subject><subject>Thyroidectomy</subject><subject>Tumors</subject><issn>1046-3976</issn><issn>1559-0097</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AOWDO</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqNkVFrFTEQhYMotlb_gA8S8EWQrZOk2WweZbEq3GrB-rxkk9k29W6yJrte7r9vdGsrPogQSCZ8Z5gzh5DnDI4ZgHqTGQfOK2C6Ai21rnYPyCGTspSg1cPyhpO6ElrVB-RJztcATADwx-RAsIY3shGH5PI8ofN29j-Qnho7x5TpEBPdmBmT2dLNfpyu6KfokJ7hbHI5PlMTHP3yzU9__vlAz83kt1uT9vTiap-id7Q1yfoQR_OUPBrMNuOz2_uIfD19d9F-qDaf339s324qK5Scq14x6XpXo2p64EZo3SjgvTE1Y9xZjVA8Dwq16U8ccid7bgcje2wYrxsH4oi8WvtOKX5fMM_d6LPFMlXAuOSOCy65bqTSBX35F3odlxTKdIWqOdNMy7pQfKVsijknHLop-bF47Bh0P2Po1hi6EkP3K4ZuV0Qvblsv_YjuTvJ77wVoVmCHfRyy9Rgs3mEAIJkuCylxAYPWz2b2MbRxCXORvv5_aaHFSudChEtM9yb_Mf8NliK0YQ</recordid><startdate>20200301</startdate><enddate>20200301</enddate><creator>Feng, Jia-Wei</creator><creator>Qin, An-Cheng</creator><creator>Ye, Jing</creator><creator>Pan, Hua</creator><creator>Jiang, Yong</creator><creator>Qu, Zhen</creator><general>Springer US</general><general>Humana Press Inc</general><general>Springer Nature B.V</general><scope>AOWDO</scope><scope>BLEPL</scope><scope>DTL</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20200301</creationdate><title>Predictive Factors for Lateral Lymph Node Metastasis and Skip Metastasis in Papillary Thyroid Carcinoma</title><author>Feng, Jia-Wei ; Qin, An-Cheng ; Ye, Jing ; Pan, Hua ; Jiang, Yong ; Qu, Zhen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-b715dbd6e78b02a3998702baa6112dc9e0120f7e9ab4de2d5b2cfa5be81268d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Biopsy</topic><topic>Endocrinology</topic><topic>Endocrinology & Metabolism</topic><topic>Life Sciences & Biomedicine</topic><topic>Lymph nodes</topic><topic>Lymphatic system</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Oncology</topic><topic>Papillary thyroid cancer</topic><topic>Papillary thyroid carcinoma</topic><topic>Pathology</topic><topic>Risk factors</topic><topic>Science & Technology</topic><topic>Thyroid cancer</topic><topic>Thyroidectomy</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Feng, Jia-Wei</creatorcontrib><creatorcontrib>Qin, An-Cheng</creatorcontrib><creatorcontrib>Ye, Jing</creatorcontrib><creatorcontrib>Pan, Hua</creatorcontrib><creatorcontrib>Jiang, Yong</creatorcontrib><creatorcontrib>Qu, Zhen</creatorcontrib><collection>Web of Science - Science Citation Index Expanded - 2020</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Endocrine pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Feng, Jia-Wei</au><au>Qin, An-Cheng</au><au>Ye, Jing</au><au>Pan, Hua</au><au>Jiang, Yong</au><au>Qu, Zhen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predictive Factors for Lateral Lymph Node Metastasis and Skip Metastasis in Papillary Thyroid Carcinoma</atitle><jtitle>Endocrine pathology</jtitle><stitle>Endocr Pathol</stitle><stitle>ENDOCR PATHOL</stitle><addtitle>Endocr Pathol</addtitle><date>2020-03-01</date><risdate>2020</risdate><volume>31</volume><issue>1</issue><spage>67</spage><epage>76</epage><pages>67-76</pages><issn>1046-3976</issn><eissn>1559-0097</eissn><abstract>In papillary thyroid cancer (PTC) patients, cervical lymph node metastases are common, which disseminate sequentially from the central neck to the lateral neck. However, there is also a chaotic pattern of lymph node metastasis occasionally. In this study, we summarized 653 PTC patients who underwent thyroidectomy and central lymph node dissection with or without lateral lymph node dissection from two hospitals to investigate the pattern and risk factors of lateral lymph node metastasis (LLNM) and skip metastasis. LLNM was significantly associated tumor size > 1 cm, presence of extrathyroidal extension, tumors in the upper-lateral pole, and the number of metastatic lymph nodes in the central compartment. The frequency of skip metastasis was 22.5% (20 of 89 patients). Multivariate analyses showed tumor size ≤ 1 cm, and tumors in the upper-lateral pole were separately and independently associated with the risk of skip metastasis. Presence of LLNM affected the recurrence-free survival (RFS). RFS did not show the significantly difference between patients with LLNM and skip metastasis. Despite the low incidence of skip metastasis, attention should be paid to the possibility of LLNM even in the absence of central lymph node metastases. Besides, for patients with risk factors of LLNM or skip metastasis, detailed preoperative examination for the lateral compartment, especially the level III, is essential.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>31828583</pmid><doi>10.1007/s12022-019-09599-w</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1046-3976 |
ispartof | Endocrine pathology, 2020-03, Vol.31 (1), p.67-76 |
issn | 1046-3976 1559-0097 |
language | eng |
recordid | cdi_proquest_miscellaneous_2325298579 |
source | SpringerLink Journals - AutoHoldings |
subjects | Biopsy Endocrinology Endocrinology & Metabolism Life Sciences & Biomedicine Lymph nodes Lymphatic system Medicine Medicine & Public Health Metastases Metastasis Oncology Papillary thyroid cancer Papillary thyroid carcinoma Pathology Risk factors Science & Technology Thyroid cancer Thyroidectomy Tumors |
title | Predictive Factors for Lateral Lymph Node Metastasis and Skip Metastasis in Papillary Thyroid Carcinoma |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T13%3A54%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predictive%20Factors%20for%20Lateral%20Lymph%20Node%20Metastasis%20and%20Skip%20Metastasis%20in%20Papillary%20Thyroid%20Carcinoma&rft.jtitle=Endocrine%20pathology&rft.au=Feng,%20Jia-Wei&rft.date=2020-03-01&rft.volume=31&rft.issue=1&rft.spage=67&rft.epage=76&rft.pages=67-76&rft.issn=1046-3976&rft.eissn=1559-0097&rft_id=info:doi/10.1007/s12022-019-09599-w&rft_dat=%3Cproquest_pubme%3E2362191956%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2362191956&rft_id=info:pmid/31828583&rfr_iscdi=true |